Patient Utilization of Opioid Destruction Bags in the Post-op Period

Not Applicable

Active, not recruiting

• Conditions: Opioid Use; Opioid Use, Unspecified; Total Hip Arthroplasty; Patient Empowerment; Total Knee Arthoplasty
• Interventions: Behavioral: Opioid destruction education

• Registration Number: NCT05875857
• Lead Sponsor: University of Nebraska

Brief Summary

This is a study on how patients use and store opioid pain medications at home after surgery and what happens to left over pills when patients are done taking them. Participants will be taught the proper storage and destruction of opioid pain medications, then contacted in 6-8 weeks about pain medication used, stored disposed of.

Detailed Description

This is a randomized single-center prospective survey study to describe the utilization of opioid destruction bags in the post-operative period. Participants who underwent surgery for Total Knee Arthroplasty (TKA) or Total Hip Arthroplasty (THA) will be eligible for inclusion if discharging to home with an opioid prescription. Eligible participants will be randomized between two groups: 1) Control group will receive current standard of care 2) Intervention group will receive a specialized handout and patient education on the safe storage of opioid medications, importance of opioid destruction, opioid destruction options and medication destruction (Deterra) bag before discharge. Participants will be phoned/emailed six to eight weeks post-surgery to complete a survey. Attempts will be made on three separate days to reach the participant via phone. If email is preferred, three reminders will be sent to complete the survey. If participant is unreachable, they will be considered lost to follow up. Survey questions will be comprised of various question styles, including: yes/no, multiple choice, and free text answers.

Study Timeline

• Study First Submitted: 2023-05-04
• Study First Submitted QC: 2023-05-16
• Study First Posted: 2023-05-25
• Study Start: 2023-06-19
• Status Verified: 2025-03
• Primary Completion: 2025-03-31
• Last Update Submitted: 2025-03-31
• Last Update Posted: 2025-04-03
• Study Completion: 2025-05

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 163

Inclusion Criteria

19 years of age or older Discharging to home and prescribed opioids at discharge post total knee arthroplasty or total hip arthroplasty

Exclusion Criteria

Under 19 years of age Opioid medication use prior to surgery Not prescribed an opioid to take after discharge

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention	Opioid destruction education	Intervention group will receive a specialized handout and patient education on the safe storage of opioid medications, importance of opioid destruction, opioid destruction options and medication destruction (Deterra) bag before discharge. Surveys will be sent to group at 6-8 weeks post discharge.

Primary Outcome Measures

Name	Time	Method
Opioid destruction	Six to Eight weeks post discharge	Opioid destruction rates-total number of subjects reporting they destroyed their un-used opioids

Secondary Outcome Measures

Name	Time	Method
Alternative opioid destruction methods	Six to Eight weeks post discharge	Utilization rate of alternate opioid destruction methods (take-back to pharmacy, mail back envelopes, flushing, etc.)-total number of subjects utilizing alternative opioid destruction methods.

Trial Locations

Locations (1)

University of Nebraska Medical Center; 🇺🇸 Omaha, Nebraska, United States